Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin.

Emary K, Moore CE, Chanpheaktra N, An KP, Chheng K, Sona S, Duy PT, Nga TV, Wuthiekanun V, Amornchai P, Kumar V, Wijedoru L, Stoesser NE, Carter MJ, Baker S, Day NP, Parry CM.

Trans R Soc Trop Med Hyg. 2012 Dec;106(12):718-24. doi: 10.1016/j.trstmh.2012.08.007. Epub 2012 Nov 1.

2.

Septic arthritis of the hip in a Cambodian child caused by multidrug-resistant Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin treated with ceftriaxone and azithromycin.

Pocock JM, Khun PA, Moore CE, Vuthy S, Stoesser N, Parry CM.

Paediatr Int Child Health. 2014 Aug;34(3):227-9. doi: 10.1179/2046905514Y.0000000123. Epub 2014 Apr 21.

PMID:
24749773
3.

Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.

Choudhary A, Gopalakrishnan R, Nambi PS, Ramasubramanian V, Ghafur KA, Thirunarayan MA.

Indian J Med Res. 2013 Apr;137(4):800-2.

4.

Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia.

Kariuki S, Revathi G, Kiiru J, Mengo DM, Mwituria J, Muyodi J, Munyalo A, Teo YY, Holt KE, Kingsley RA, Dougan G.

J Clin Microbiol. 2010 Jun;48(6):2171-6. doi: 10.1128/JCM.01983-09. Epub 2010 Apr 14.

5.
6.

Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.

Madhulika U, Harish BN, Parija SC.

Indian J Med Res. 2004 Aug;120(2):111-4.

PMID:
15347861
7.

Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.

Kasper MR, Sokhal B, Blair PJ, Wierzba TF, Putnam SD.

Diagn Microbiol Infect Dis. 2010 Feb;66(2):207-9. doi: 10.1016/j.diagmicrobio.2009.09.002. Epub 2009 Oct 2.

PMID:
19800753
8.

Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin.

Misra R, Prasad KN, Amrin N, Kapoor P, Singh S, Ghar M.

Trans R Soc Trop Med Hyg. 2015 Aug;109(8):538-40. doi: 10.1093/trstmh/trv036. Epub 2015 May 15.

PMID:
25979527
9.

Trends in antibiotic susceptibility of enteric fever isolates in East London.

Dave J, Sefton A, de Pinna E, Woodford N, Meade R, Jordan M, Grant K, Holliman R, Millar M.

Travel Med Infect Dis. 2015 May-Jun;13(3):230-4. doi: 10.1016/j.tmaid.2015.04.001. Epub 2015 Apr 23.

PMID:
25964222
10.

Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.

Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, Deb M, Aggarwal P, Rubino S.

J Antimicrob Chemother. 2006 Dec;58(6):1139-44. Epub 2006 Oct 28.

PMID:
17071955
11.

Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012.

Das S, Samajpati S, Ray U, Roy I, Dutta S.

Int J Med Microbiol. 2017 Jan;307(1):28-36. doi: 10.1016/j.ijmm.2016.11.006. Epub 2016 Nov 25.

PMID:
27916384
12.

Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.

Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.

BMC Infect Dis. 2004 Sep 20;4:36.

13.

Temporal fluctuation of multidrug resistant salmonella typhi haplotypes in the mekong river delta region of Vietnam.

Holt KE, Dolecek C, Chau TT, Duy PT, La TT, Hoang NV, Nga TV, Campbell JI, Manh BH, Vinh Chau NV, Hien TT, Farrar J, Dougan G, Baker S.

PLoS Negl Trop Dis. 2011 Jan 4;5(1):e929. doi: 10.1371/journal.pntd.0000929.

14.

A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.

Al-Emran HM, Eibach D, Krumkamp R, Ali M, Baker S, Biggs HM, Bjerregaard-Andersen M, Breiman RF, Clemens JD, Crump JA, Cruz Espinoza LM, Deerin J, Dekker DM, Gassama Sow A, Hertz JT, Im J, Ibrango S, von Kalckreuth V, Kabore LP, Konings F, Løfberg SV, Meyer CG, Mintz ED, Montgomery JM, Olack B, Pak GD, Panzner U, Park SE, Razafindrabe JL, Rabezanahary H, Rakotondrainiarivelo JP, Rakotozandrindrainy R, Raminosoa TM, Schütt-Gerowitt H, Sampo E, Soura AB, Tall A, Warren M, Wierzba TF, May J, Marks F.

Clin Infect Dis. 2016 Mar 15;62 Suppl 1:S42-6. doi: 10.1093/cid/civ788.

15.

Genomic signature of multidrug-resistant Salmonella enterica serovar typhi isolates related to a massive outbreak in Zambia between 2010 and 2012.

Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, Lukwesa-Musyani C, Tambatamba B, Mwaba J, Kalonda A, Nakazwe R, Kwenda G, Jensen JD, Svendsen CA, Dittmann KK, Kaas RS, Cavaco LM, Aarestrup FM, Hasman H, Mwansa JC.

J Clin Microbiol. 2015 Jan;53(1):262-72. doi: 10.1128/JCM.02026-14. Epub 2014 Nov 12.

16.

Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).

Singhal L, Gupta PK, Kale P, Gautam V, Ray P.

Indian J Med Microbiol. 2014 Apr-Jun;32(2):149-52. doi: 10.4103/0255-0857.129799.

17.

Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh.

Rahman M, Siddique AK, Shoma S, Rashid H, Salam MA, Ahmed QS, Nair GB, Breiman RF.

Epidemiol Infect. 2006 Apr;134(2):433-8.

18.

Antimicrobial resistance in Salmonella enterica Serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam.

Chiou CS, Lauderdale TL, Phung DC, Watanabe H, Kuo JC, Wang PJ, Liu YY, Liang SY, Chen PC.

Antimicrob Agents Chemother. 2014 Nov;58(11):6501-7. doi: 10.1128/AAC.03608-14. Epub 2014 Aug 18.

19.

[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].

Gaborieau V, Weill FX, Marchou B.

Med Mal Infect. 2010 Dec;40(12):691-5. doi: 10.1016/j.medmal.2010.06.009. Epub 2010 Aug 17. French.

PMID:
20724089
20.

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.

Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, Tung le T, Tham NT, Wain J, Hien TT, Farrar JJ.

Antimicrob Agents Chemother. 2007 Mar;51(3):819-25. Epub 2006 Dec 4.

Supplemental Content

Support Center